Susan Brown

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

New-Onset Diabetes Mellitus and Diabetic Ketoacidosis Associated With Olanzapine Treatment

Lee E. Goldstein, Jonathan Sporn, Susan Brown et al. · Psychosomatics · 1999 · 220 citations

Diabetes Management, Diabetes, Pharmacology +4

Rechallenge with lamotrigine after initial rash

Simon Tavernor, Ian Chi Kei Wong, Richard Newton et al. · Seizure · 1995 · 64 citations · Full text

Initial Rash, Dermatology, Clinical Infectious Disease

Relapse of neuroleptic malignant syndrome with early discontinuation of amantadine therapy

Paul Hamburg, Jeffrey B. Weilburg, Ned H. Cassem et al. · Comprehensive Psychiatry · 1986 · 23 citations · Full text

Neuro-oncology, Early Discontinuation, Amantadine Therapy +5